Through bioinformatic analysis, we identified four MAM domain-containing genes (EGFL6, MEP1A, MEP1B, and MAMDC2) that showed significant differential expression between tumor and adjacent normal tissues in CRC. This evidence concerns the gene MEP1B and neoplasm.